Back

Post-vaccination expansion of extrafollicular Th10 and regulatory Tfr cells distinguishes strong from weak influenza vaccine responses in older adults

Mahajan, A. S.; Ravichandran, S.; Marches, R.; Yazici, Y. Y.; Nelson, S.; Aydillo Gomez, T.; Kshitija, K.; Rojo Fernandez, A.; Nehar-Belaid, D.; Kenyon Pesce, L.; Klimes, D.; Jung, H.; Sage, P. T.; Pascual, V.; Wilson, P.; Garcia Sastre, A.; Banchereau, J.; Kuchel, G. A.; Ucar, D.

2026-07-06 allergy and immunology
10.64898/2026.07.02.26357118 medRxiv
Show abstract

Despite the superior efficacy of high-dose influenza vaccines, over one-third of older adults fail to respond. Yet, the mechanisms underlying this impaired vaccine responsiveness remain poorly understood. Here, we performed longitudinal profiling of older adults (n=60) receiving high-dose influenza vaccination to identify immune programs associated with vaccine responsiveness. Strong responders exhibited a primed baseline immune state characterized by elevated plasma cytokines and chemokines, followed by enhanced IFN-{gamma} responses and coordinated transcriptional and epigenetic activation of cDC2 cells at day 1. By day 7, CD4+ T-cell trajectories diverged: strong responders preferentially expanded influenza-specific activated cTfh1 (CXCR5+ CXCR3+ ICOS+ CD38+) and influenza-specific Th10 (CXCR5- CXCR3+ PD1+ IL10+) cells, whereas weak responders expanded regulatory cTfr (CXCR5+ FOXP3+) cells. Th10 expansion correlated with plasmablast and antibody responses and was independently validated in a larger influenza vaccination cohort, including younger adults. Functionally, Th10 cells promoted memory B-cell differentiation into plasmablasts and production of influenza-specific IgGs. TCR analyses revealed minimal clonal overlap between Th10 and cTfh1 cells. Together, these findings identify divergent helper and regulatory CD4+ T cell programs associated with vaccine responsiveness and establish Th10 cells as a previously unrecognized component of vaccine-induced humoral immunity.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 15%
12.1%
2
Cell Reports
1498 papers in training set
Top 2%
11.5%
3
Mucosal Immunology
47 papers in training set
Top 0.1%
9.4%
4
The Journal of Immunology
166 papers in training set
Top 0.4%
6.5%
5
Immunity
67 papers in training set
Top 0.2%
6.5%
6
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 8%
6.1%
50% of probability mass above
7
Molecular Psychiatry
282 papers in training set
Top 2%
3.9%
8
Nature Immunology
79 papers in training set
Top 0.8%
3.4%
9
Journal of Clinical Investigation
179 papers in training set
Top 1%
3.3%
10
Cell Reports Medicine
153 papers in training set
Top 1%
3.1%
11
Science Advances
1243 papers in training set
Top 14%
2.6%
12
JCI Insight
277 papers in training set
Top 3%
2.3%
13
Journal of Experimental Medicine
119 papers in training set
Top 1%
2.3%
14
eLife
5828 papers in training set
Top 50%
1.7%
15
Frontiers in Immunology
638 papers in training set
Top 6%
1.7%
16
Science Immunology
88 papers in training set
Top 2%
1.4%
17
mBio
833 papers in training set
Top 9%
1.3%
18
Nature Medicine
125 papers in training set
Top 2%
1.3%
19
eBioMedicine
183 papers in training set
Top 4%
1.3%
20
Cell Genomics
172 papers in training set
Top 3%
1.1%
21
Aging Cell
165 papers in training set
Top 2%
1.1%
22
EMBO Reports
263 papers in training set
Top 7%
1.0%
23
Science
477 papers in training set
Top 8%
1.0%
24
GeroScience
109 papers in training set
Top 2%
0.8%
25
PLOS Pathogens
820 papers in training set
Top 10%
0.8%
26
Nature
645 papers in training set
Top 11%
0.8%
27
Cell
431 papers in training set
Top 12%
0.6%
28
Science Translational Medicine
127 papers in training set
Top 5%
0.6%
29
Communications Medicine
113 papers in training set
Top 6%
0.6%
30
npj Vaccines
67 papers in training set
Top 1.0%
0.6%